AI team introduces ProteinMPNN-ddG for estimating protein stability changes from mutations, enhancing speed and efficiency with GPU support.

Kamil Tamiola’s approach to better understand disease-causing proteins reflects his passion to study protein disorders.

Peptone AI team presents our Sentence Transformers research during NeurIPS 2023 Conference.

I'm thrilled to announce that I will be attending the annual JP Morgan Healthcare Investment Conference in San Francisco in 2024.

Peptone and The Institute of Oncology Research (IOR) Bellinzona announce collaborative research agreement aimed at prostate cancer.

Peptone featured in PWC’s

Future50, a spotlight on the transformational science and innovation pioneered by UK life sciences companies.

Peptone’s Chief Executive Officer, Dr. Kamil Tamiola, and our Chief Business Officer, Dr. Benjamin Owens, were featured in an editorial issue titled“Peptone: Finding Opportunity in Disorder” by Michael Eisenstein of Nature Biotechnology.

We have expanded our executive team at Peptone.

Peptone and StudioGusto win a prestigious FWA award for website and brand identity design